Sort by
Refine Your Search
-
) Sydney, in partnership with ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak
-
Health . The role of Post-Doctoral Fellow reports to the Deputy Director, Implementation to Impact program, and will have one direct report. Some key skills required: A PhD in a related discipline, and/or
-
focused on understanding and countering harmful narratives and, mis/disinformation, and applying social network analysis. To be successful you will need: PhD in a relevant discipline such as computer
-
) A PhD in a related discipline, and/or relevant work experience. Experience in at least two of the following areas: engineering design, thermodynamics calculations, heat transfer, fluid flow, radiation
-
ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak reactors. We are recruiting
-
the following key capabilities: A PhD in a relevant field Demonstrated experience working with ecological datasets Demonstrated experience in statistical inference and reporting Knowledge of models and theory in
-
PhD in a related area: Mathematics, Computer Science, or Engineering, and have an aptitude and demonstrated capability to publish in top ranked avenues in their field of study. Depending on experience
-
combatting wildlife trafficking and environmental harm. To be successful you will need: PhD in a relevant discipline such as computer science, data science, digital forensics, cyber security or a related field
-
predictive control, and/or reinforcement learning. PhD (or soon to be completed) in engineering, applied mathematics, or computer science, with an ability to start in mid-late 2025 a research track record
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural